颗粒混合型侧向发育型肿瘤隐匿性黏膜下癌风险
该研究纳入意大利7个中心2016至2019年693例无侵袭征象的结直肠颗粒混合型侧向发育型肿瘤患者,74.2%接受内镜下切除术、25.2%接受内镜黏膜下剥离术。病理分析显示66例(9.5%)存在隐匿性黏膜下浸润癌,多因素分析显示病变增大(每增1mm OR 1.02)和直肠位置(OR 3.08)与风险独立相关。结论认为约10%的GM-LST存在隐匿性SMIC,≥4cm及直肠位置为高风险,应行整块切除。
要点
- 693例无侵袭征象的结直肠GM-LST中,66例(9.5%)病理证实为隐匿性黏膜下浸润癌。
- 病变每增大1mm,隐匿性SMIC风险增加(OR 1.02,95%CI 1.01-1.03,P=.003)。
- 直肠位置与隐匿性SMIC风险独立相关(OR 3.08,95%CI 1.62-5.83,P=.004)。
核心结论
- 在693例患者的数据分析中,GM-LST患者隐匿性SMIC风险约为10%。
- ≥4cm的GM-LST及直肠位置属高风险,应行整块切除。
研究设计与样本
- 多中心研究,收集意大利7个中心2016至2019年693例无侵袭征象的结直肠GM-LST患者数据。
- 患者中男性50.6%,中位年龄69岁;74.2%接受内镜下切除术,25.2%接受内镜黏膜下剥离术。
- 采用单因素和多因素分析识别与SMIC风险相关的 demographic 和内镜因素,并建立多因素模型计算需治疗人数(NNT)。
主要发现
- 病理分析显示66例(9.5%)存在隐匿性SMIC。
- 多因素分析中,病变增大与隐匿性SMIC风险独立相关(每增1mm OR 1.02,95%CI 1.01-1.03,P=.003)。
- 直肠位置与隐匿性SMIC风险独立相关(OR 3.08,95%CI 1.62-5.83,P=.004)。
- 基于病变大小( cutoff 40mm)和直肠位置的逻辑回归模型识别隐匿性SMIC的敏感性47.0%、特异性82.6%、曲线下面积0.69。
- 识别1例非直肠<4cm的SMIC的NNT为20;识别1例直肠≥4cm的SMIC的NNT为5。
关键数值与推荐
- 病变大小 cutoff 值为40mm,联合直肠位置构建的逻辑回归模型敏感性47.0%、特异性82.6%、AUC 0.69。
- 非直肠、病变<4cm者识别1例SMIC的NNT为20;直肠、病变≥4cm者识别1例SMIC的NNT为5。
临床怎么用
- 作者认为≥4cm的GM-LST及直肠位置为高风险,应行整块切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Granular mixed laterally spreading tumors (GM-LSTs) have an intermediate level of risk for submucosal invasive cancer (SMICs) without clear signs of invasion (covert); the optimal resection method is uncertain. We aimed to determine the risk of covert SMIC in GM-LSTs based on clinical and endoscopic factors. METHODS: We collected data from 693 patients (50.6% male; median age, 69 years) with colorectal GM-LSTs, without signs of invasion, who underwent endoscopic resection (74.2%) or endoscopic submucosal dissection (25.2%) at 7 centers in Italy from 2016 through 2019. We performed multivariate and univariate analyses to identify demographic and endoscopic factors associated with risk of SMIC. We developed a multivariate model to calculate the number needed to treat (NNT) to detect 1 SMIC. RESULTS: Based on pathology analysis, 66 patients (9.5%) had covert SMIC. In multivariate analyses, increased risk of covert SMIC were independently associated with increasing lesion size (odds ratio per mm increase, 1.02, 95% CI, 1.01-1.03; P = .003) and rectal location (odds ratio, 3.08; 95% CI, 1.62-5.83; P = .004). A logistic regression model based on lesion size (with a cutoff of 40 mm) and rectal location identified patients with covert SMIC with 47.0% sensitivity, 82.6% specificity, and an area under the curve of 0.69. The NNT to identify 1 patient with a nonrectal SMIC smaller than 4 cm was 20; the NNT to identify 1 patient with a rectal SMIC of 4 cm or more was 5. CONCLUSIONS: In an analysis of data from 693 patients, we found the risk of covert SMIC in patients with GM-LSTs to be approximately 10%. GM-LSTs of 4 cm or more and a rectal location are high risk and should be treated by en-bloc resection. ClinicalTrials.gov, Number: NCT03836131.
引用
- D'Amico F, Amato A, Iannone A, et al. Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors. Clin Gastroenterol Hepatol. 2020. PMID: 32687977. doi:10.1016/j.cgh.2020.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。